Latest Developments in Global Personalized Orthopedics Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Personalized Orthopedics Market

  • Healthcare
  • Dec 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In October 2024, Sparsh Hospitals launched India’s first advanced on-site 3D printing lab, introducing state-of-the-art technology to revolutionize orthopedic and personalized medical care. The facility provides a seamless solution, from scanning to the creation of customized models, under one roof
  • In May 2024, Create it REAL, a Danish 3D printing R&D center specializing in orthopedics, announced the upcoming launch of a digital ordering platform at the OTWorld trade show in Leipzig, Germany. This platform aims to simplify access to its custom orthopedic production services, allowing professionals to focus on the product rather than the technology
  • In February 2024, Prescribe FIT, a leader in remote patient monitoring (RPM) and virtual lifestyle coaching for musculoskeletal health, secured USD 4.8 million in Series A funding. The funds will support the hiring of health coaches with clinical expertise to deliver personalized care and guidance to patients
  • In July 2022, Onkos Surgical received 510(k) clearance for its My3D Personalized Pelvic Reconstruction system. This innovative solution includes 3D-printed implants, instruments, models, and advanced planning services, designed to address complex cases of deformity, trauma, and disease
  • In August 2021, Monogram Orthopedics surpassed the milestone of 5,000 Series B investors on the crowdfunding platform StartEngine. The company is focused on transforming the USD 19.6 billion joint replacement market using AI, robotics, and 3D printing, targeting a USD 34 million raise to scale its operations and submit its first total knee arthroplasty (TKA) implant for FDA approval